FDA Brief

Company record

Dermal Source, Inc.

1 FDA warning letter since 2023 and 0 recalls in the last 12 months.

Get an email the day FDA posts anything new about Dermal Source, Inc..

Warning letters

  1. Dermal Source, Inc.

    FDA warned Dermal Source that five topical anesthetic products are unapproved and misbranded drugs with lidocaine above OTC limits.

    High risk